Risk of major adverse cardiovascular events, severe hypoglycemia, and all-cause mortality for widely used antihyperglycemic dual and triple therapies for type 2 diabetes management: a cohort study of all Danish users
A large overlap in neuronal activity patterns was observed between the two treatments and, in agreement with previous research 37 , strong signals were detected in the arcuate nucleus, in the central amygdala and in subregions of the brainstem, including the area postrema, the nucleus of the solitary tract and the dorsal motor nucleus of the vagus nerve (Fig
No oral formulation of retatrutide has been publicly announced or registered in clinical trials as of April 2026 (based on available information from Eli Lilly's published pipeline and ClinicalTrials.gov)
Understanding whether tirzepatide burns fat or just suppresses appetite and whether tirzepatide increases metabolism helps calibrate realistic expectations about the mechanism
The effects of the NAD + intermediates on longevity and healthy life expectancy have recently gained attention
The Homeostatic Force of Ghrelin